Katie M Gallagher Selected Research

Diethylstilbestrol (Stilbestrol)

12/2012

Expression of a dominant negative estrogen receptor alpha variant in transgenic mice accelerates uterine cancer induced by the potent estrogen diethylstilbestrol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katie M Gallagher Research Topics

Disease

2	Neoplasms (Cancer) 01/2019 - 12/2012
2	Carcinogenesis 12/2012 - 12/2012
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Cataract (Cataracts) 07/2013
1	Adenocarcinoma 12/2012
1	Uterine Neoplasms (Uterine Cancer) 12/2012
1	Retinal Degeneration 11/2012
1	Thrombosis (Thrombus) 12/2008
1	Infarction (Infarctions) 12/2008
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2008
1	Stroke (Strokes) 12/2008
1	Inflammation (Inflammations) 12/2008
1	Compression Fractures (Compression Fracture) 05/2006

Drug/Important Bio-Agent (IBA)

3	Estrogens (Estrogen)FDA Link 07/2013 - 12/2012
2	MelatoninIBA 01/2019 - 11/2012
1	AmphiregulinIBA 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Progesterone FDA LinkGeneric 01/2019
1	Estrogen ReceptorsIBA 12/2012
1	Soybean Proteins (Soy Protein)IBA 12/2012
1	Estrogen Receptor alphaIBA 12/2012
1	IsoflavonesIBA 12/2012
1	Tamoxifen FDA LinkGeneric 12/2012
1	Diethylstilbestrol (Stilbestrol)FDA Link 12/2012
1	complement C4dIBA 12/2008
1	Biomarkers (Surrogate Marker)IBA 12/2008
1	Anticardiolipin AntibodiesIBA 12/2008

Therapy/Procedure

2	Therapeutics 01/2019 - 05/2006